Government policies are among the major challenges before companies operating in the life sciences sector in the Asia Pa...
Growing on its legacy of 127 years, Dabur India clocked $847 million in 2012. The company is recognized for manufactur...
A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing ...
BioSpectrum Technology Forum 2015 was successfully concluded on August 14th, 2015 at The Taj Krishna, Hyderabad. Team Bi...
Life sciences has been chosen as one of the sectors that the autonomous Scottish government of Mr Alex Salmond is giving...
The global bioscience industry, in 2012, reported 450 mergers and acquisitions (M&A) transactions valued at $67 bill...
I graduated from Chulalongkorn University with a BS in Genetics, enrolled at the University of Connecticut, US, to conti...
Yunnan Baiyao Group is expanding its forte in the domain of traditional Chinese medicines and is concentrating on stre...
Development of stem cell therapies requires innovative technologies and processes to overcome safety concerns and VeriSt...
Malaysia-based AseaCyte is emerging as an instrumental firm in the domain of human disease analysis, through its cell cu...
Clocking $1.3 billion revenue in 2012, Guangzhou Pharmaceutical recorded a growth of over 50 percent. A well-recognize...
The bioscience industry is about to step into 2013 and the year is predicted to unfold with new opportunities and trends...
Most pharmaceutical companies are sitting on the patent cliff and their drug pipelines are facing severe exhaustion. The...
A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing ...
Nearly three million new TB cases occur in South East Asia per year. Annually, about 700,000 women die of TB in Asia, an...
The Global Alliance for TB Drug Development (TB Alliance) is a non-profit organization dedicated to the discovery and de...
The fact that one-fifth of the world's TB patients are in India (according to WHO) acts as a good catalyst for companies...
Sandoz is the generic drug subsidiary of Novartis, a multinational pharmaceutical company. The company develops, manufac...
Tibotec is an international pharmaceutical company, accelerating discovery and development of breakthrough drugs in HIV/...
A meeting between Dr Teo Soo Hwang, current CEO of AseaCyte; Dr Lee Hong Boon from Cancer Research Initiatives Foundatio...
The Global Fund to Fight AIDS, Tuberculosis and Malaria, is a public-private partnership dedicated to attracting and dis...
The Stop TB Partnership was established in 2000 to realize the goal of eliminating Tuberculosis (TB) as a public health ...
Low monetary return on TB drug R&D has prevented even the biggest of pharmaceutical and biotech companies from ventu...
Pre-menopausal South Asian women could be more at risk of developing osteoporosis in later life than white Caucasian wom...
